Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

Supplementary Figure S2 from Blood-Based Genomic Alteration Signature for Predicting Progression-Free Survival in <i>De Novo</i> Metastatic Hormone-Sensitive Prostate Cancer: A Real-World Study

<p>Figure S2. Nomogram for predicting progression-free survival (PFS) based on t.TRPC and disease volume score.</p>

Salvato in:

Dettagli Bibliografici
Autore principale:	Ruiliang Wang (17333340) (author)
Altri autori:	Jing Xu (22749676) (author), Chenyi Zhu (22749679) (author), Wujianhong Liu (22749682) (author), Chengqi Jin (22749685) (author), Wentao Luo (22749688) (author), Tingting Zhao (17333385) (author), Changcheng Guo (17333361) (author), Wei Chen (22749691) (author), Bin Yang (17333400) (author)
Pubblicazione:	2025
Soggetti:	Cancer Cancer Detection and Diagnosis Methods and Technology Biomarkers Circulating tumor cells/DNA/exosomes Genitourinary Cancers Liquid Biopsy Prostate Cancer
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Lascia un commento!